Wednesday, February 10, 2010, 4:21am EST - Canadian Markets open in 5 hours and 9 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

ArQule Inc. (ARQL)

 On Feb 9: 3.09 USD   0.00 (0.00%)  
MORE ON ARQL
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
ArQule, Inc. (NGM:ARQL) Delayed quote dataEdit
Last Trade: 3.09 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 3.09
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 8.08
Day's Range: N/A - N/A
52wk Range: 2.62 - 6.38
Volume: 0
Avg Vol (3m): 178,330
Market Cap: 138.09M
P/E (ttm): N/A
EPS (ttm): -0.81
Div & Yield: N/A (N/A%)
ArQule Inc. (ARQL)
1d  5d  3m  6m  1y  2y  5y  max 
 Add ARQL to Portfolio   Download Data

HEADLINES
• ArQule Announces Initiation of Clinical Programs with ARQ 197 in Germ Cell Tumors and Colorectal Cancer
Business Wire (Thu, Feb 4)
• Local insider sales topped $279M in Q4
at bizjournals.com (Wed, Jan 13)
• Acetylon Pharma lands $2M in financing
at bizjournals.com (Mon, Jan 11)
• [$$] ArQule and Magellan Health Rise
at The Wall Street Journal Online (Tue, Dec 22)
• [$$] Icahn Buys Stake in Take-Two, Boosting Small Tech Stocks
at The Wall Street Journal Online (Fri, Dec 18)
• [$$] Rate, Credit Worries Hit Small-Caps
at The Wall Street Journal Online (Thu, Dec 17)
• Positive Results for ARRY-380
Zacks.com (Mon, Dec 14)
• ArQule, Inc.: Warming Up or Cooling Off?
at Motley Fool (Thu, Nov 19)
• Drug Discovery Capabilities of ArQule Kinase Inhibitor Platform Presented at AACR-NCI-EORTC Conference
Business Wire (Mon, Nov 16)
• ARQULE INC Financials
EDGAR Online Financials (Wed, Nov 11)
• ARQULE INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 6)
More Headlines for ARQL...
ANALYST
EPS Est (next year) (Dec-09) : -0.83
EPS Est (in 2 years) (Dec-10) : -0.88
Avg Rec (current)*: 1.3
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
ArQule, Inc., a clinical-stage biotechnology company, engages in the research and development of cancer therapeutics directed toward molecular targets.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices